Evaluation of Lysyl Oxidase-Like-2 (LOXL2) Expression by Immunohistochemistry (IHC) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): A Retrospective Analysis and Comparison with PTEN

#966

Introduction: A better understanding of the relationship between the stroma and the cancer cells of this group of malignancies remains a challenge. LOXL2 is an enzyme that contributes to the synthesis and stabilization of the cellular matrix and plays a role in angiogenesis.

Aim(s): To study the prognostic value of LOXL2 expression by IHC.

Materials and methods: One-hundred and fourteen patients (pts) underwent surgery for GEP-NET from 1980 to 2012 at La Paz Hospital. Tissue microarrays (TMAs) were constructed with 109 available formalin-fixed and paraffin embedded samples. The study was approved by an Ethics Committee.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Barriuso J

Authors: Barriuso J, Bernal E, Pastrian L, Alvárez-Escolá C, Martinez J,

Keywords: LOXL2, GEP-NET,

To read the full abstract, please log into your ENETS Member account.